Ads
related to: cochrane reviews and evaluations of people with dementia- Doctor Discussion Guide
Learn More About How
To Approach Your Doctor
- Patient Resources
Information About Managing
Agitation in Alzheimer's Dementia.
- Doctor Discussion Guide
wiserlifestyles.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
This is in contrast to conventional dementia screening tests like the Mini-Mental State Examination, which are affected by education and intelligence as well as the presence of dementia. [3] A Cochrane review conducted in 2021 focused on the use of the IQCODE in primary care settings for the detection of dementia was unable to provide any ...
However, there is some evidence that RT can improve quality of life, cognition, communication and possibly mood in people with dementia in some circumstances, although all the benefits were small. A recent Cochrane review (2018) concluded that reminiscence therapy can improve quality of life, cognition, communication and possibly mood in people ...
The higher cut-off score has both high specificity and sensitivity and is at least five times more likely to have come from a dementia patient than without. A score of 21 or less is almost certainly diagnostic of a dementia syndrome regardless of the clinical setting. [16] It has been found to be superior to the MMSE in diagnostic utility. [17 ...
Researchers examined all studies between 1984 and 2024 which reported on survival or nursing home admission for people with dementia. A total of 235 studies reported on survival among more than 5. ...
The Cochrane Library (named after Archie Cochrane) is a collection of databases in medicine and other healthcare specialties provided by Cochrane and other organizations. At its core is the collection of Cochrane Reviews, a database of systematic reviews and meta-analyses that summarize and interpret the results of medical research.
Cochrane, previously known as the Cochrane Collaboration, was founded in 1993 under the leadership of Iain Chalmers. [10] It was developed in response to Archie Cochrane's call for up-to-date, systematic reviews of all relevant randomised controlled trials in the field of healthcare.
Ads
related to: cochrane reviews and evaluations of people with dementia